Literature DB >> 31197643

Little Children, Bigger Problems: Anti-N-Methyl D-Aspartate Receptor Encephalitis!

Ashwini Prithvi1, Shivan Kesavan1, Arushi Gahlot Saini2, Renu Suthar1, Anita Mahadevan3.   

Abstract

Anti N-methyl D-aspartate receptor (NMDAR) antibody positive autoimmune encephalitis is a well-described entity both in adults as well as in children. The authors report an 18-mo-old boy who presented with seizures, movement disorder, cognitive impairment, and behavioral disturbances. Anti-NMDAR encephalitis was confirmed by detection of NMDAR antibodies in the cerebrospinal fluid. The patient was administered pulse corticosteroids and intravenous immunoglobulin followed by further immunomodulatory therapy. No tumor was detected on screening. The child remained unresponsive to treatment. The authors wish to highlight the occurrence of anti-NMDAR encephalitis in young toddlers and the poor response to therapy often seen in very young children.

Entities:  

Keywords:  Anti-N-methyl D-aspartate; Autoimmune encephalitis; Encephalitis; Infant; NMDAR

Mesh:

Substances:

Year:  2019        PMID: 31197643     DOI: 10.1007/s12098-019-03000-8

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  9 in total

1.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

Review 2.  Plasma exchange in pediatric anti-NMDAR encephalitis: A systematic review.

Authors:  Agnese Suppiej; Margherita Nosadini; Luigi Zuliani; Maria Federica Pelizza; Irene Toldo; Chiara Bertossi; Tiziana Tison; Marco Zoccarato; Piero Marson; Bruno Giometto; Russell C Dale; Stefano Sartori
Journal:  Brain Dev       Date:  2016-02-28       Impact factor: 1.961

3.  Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients.

Authors:  Thaís Armangue; Maarten J Titulaer; Ignacio Málaga; Luis Bataller; Iñigo Gabilondo; Francesc Graus; Josep Dalmau
Journal:  J Pediatr       Date:  2012-11-16       Impact factor: 4.406

Review 4.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Authors:  Josep Dalmau; Eric Lancaster; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

5.  Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study.

Authors:  Julia Granerod; Helen E Ambrose; Nicholas Ws Davies; Jonathan P Clewley; Amanda L Walsh; Dilys Morgan; Richard Cunningham; Mark Zuckerman; Ken J Mutton; Tom Solomon; Katherine N Ward; Michael Pt Lunn; Sarosh R Irani; Angela Vincent; David Wg Brown; Natasha S Crowcroft
Journal:  Lancet Infect Dis       Date:  2010-10-15       Impact factor: 25.071

6.  Efficacy of Therapeutic Plasma Exchange in Patients with Severe Refractory Anti-NMDA Receptor Encephalitis.

Authors:  Yan Zhang; Gang Liu; Mengdi Jiang; Weibi Chen; Yingying Su
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 7.  Autoimmunity in immunodeficiency.

Authors:  Krista Todoric; Jessica B Koontz; Daniel Mattox; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

Review 8.  C1q, autoimmunity and apoptosis.

Authors:  Marina Botto; Mark J Walport
Journal:  Immunobiology       Date:  2002-09       Impact factor: 3.144

9.  Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis.

Authors:  Thaís Armangue; Marianna Spatola; Alexandru Vlagea; Simone Mattozzi; Marc Cárceles-Cordon; Eloy Martinez-Heras; Sara Llufriu; Jordi Muchart; María Elena Erro; Laura Abraira; German Moris; Luis Monros-Giménez; Íñigo Corral-Corral; Carmen Montejo; Manuel Toledo; Luis Bataller; Gabriela Secondi; Helena Ariño; Eugenia Martínez-Hernández; Manel Juan; Maria Angeles Marcos; Laia Alsina; Albert Saiz; Myrna R Rosenfeld; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2018-07-23       Impact factor: 44.182

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.